KYMR
Kymera Therapeutics Inc (KYMR) Investor Questions
Review Kymera Therapeutics Inc (KYMR) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Kymera Therapeutics Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 63
- Annual revenue
- $39.21M
- Annual net income
- $311.35M
- Annual free cash flow
- $-234.34M
Kymera Therapeutics Inc (KYMR) Investor Questions research
Kymera Therapeutics Inc trades under the ticker KYMR. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review KYMR through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.